-transparent.png){kind=logo}
In an attempt to compare the effects of transdermal and oral conjugated estrogen on serum lipoproteins, 35 premenopausal women who underwent total abdominal hysterectomy and bilateral salpingo-oophorectomy were randomized to receive either 0.625 mg of conjugated oral estrogen or 0.05 mg transdermal 17 beta-E2 during the first postoperative year. Lipid profiles were assessed before surgery and at 3, 6, 9, and 12 months of therapy in each subject. Neither oral nor transdermal estrogen replacement therapy produced significant changes on serum lipoproteins at the end of first year when compared with baseline preoperative values. We conclude that both transdermal and oral administration of estrogen are promising in the maintenance of premenopausal lipid values after menopause.
M Erenus, and
K Kutlay, and
L Kutlay, and
S Pekin
March 1992,
American journal of obstetrics and gynecology,
M Erenus, and
K Kutlay, and
L Kutlay, and
S Pekin
September 2001,
Climacteric : the journal of the International Menopause Society,
M Erenus, and
K Kutlay, and
L Kutlay, and
S Pekin
November 2020,
Menopause (New York, N.Y.),
M Erenus, and
K Kutlay, and
L Kutlay, and
S Pekin
January 1998,
Menopause (New York, N.Y.),
M Erenus, and
K Kutlay, and
L Kutlay, and
S Pekin
May 1996,
Journal of endocrinological investigation,
M Erenus, and
K Kutlay, and
L Kutlay, and
S Pekin
May 1989,
Clinical pharmacy,
M Erenus, and
K Kutlay, and
L Kutlay, and
S Pekin
August 2008,
Metabolism: clinical and experimental,
M Erenus, and
K Kutlay, and
L Kutlay, and
S Pekin
February 1996,
Fertility and sterility,
M Erenus, and
K Kutlay, and
L Kutlay, and
S Pekin
April 2013,
Journal of pediatric and adolescent gynecology,
M Erenus, and
K Kutlay, and
L Kutlay, and
S Pekin
January 2002,
Journal of bone and mineral metabolism,
